Biphasic effect of sigma receptor ligands on the extracellular concentration of dopamine in the striatum of the rat

Journal of Neural Transmission

Volumn 106, Issue 9-10, 1999, Pages 849-856

  Gudelsky, G A ^a,b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

(+) Pentazocine; Di o tolylguanidine; Dopamine; NMDA receptor; Sigma receptor; Striatum

Indexed keywords

DOPAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PENTAZOCINE; SIGMA OPIATE RECEPTOR; SIGMA RECEPTOR LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALGESICS, OPIOID; ANIMALS; ANTICONVULSANTS; CORPUS STRIATUM; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; GUANIDINES; LIGANDS; MALE; MICRODIALYSIS; PENTAZOCINE; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA;

EID: 0032727034     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050205     Document Type: Article

References (17)

1. 3H]dopamine release from rat striatum by neuropeptide Y and σ receptor ligands. Brain Res 760: 210-217
2. 3H]dopamine release from rat nucleus accumbens by neuropeptide Y may involve a sigma 1-like receptor. J Pharmacol Exp Ther 284: 553-560
3. Booth R, Baldessarini RJ (1992) (+)-6,7-Benzomorphan sigma ligands stimulate dopamine synthesis in rat corpus striatum tissue. Brain Res 557: 349-352
4. Goldstein SR, Matsumoto RR, Thompson TL, Patrick R, Bowen WD, Walker JM (1989) Motor effects of two sigma ligands mediated by nigrostriatal dopamine neurons. Synapse 4: 254-258
5. 3H]dopamine release from rat striatal slices by sigma receptor ligands. J Pharmacol Exp Ther 271: 211-219
6. 3H]dopamine release via a presynaptic mechanism. Eur J Pharmacol 294: 713-719
7. Gudelsky GA (1995) Effects of a receptor ligands on the extracellular concentration of dopamine in the striatum and prefrontal cortex of the rat. Eur J Pharmacol 286: 223-228
8. Gudelsky GA, Nash JF (1992) Neuroendocrinological and neurochemical effects of sigma ligands. Neuropharmacology 31: 157-162
9. 3H-3-(3-hydroxyphenyl)N-(1-propyl)-piperidine. J Neurosci 6: 1757-1770
10. Iyengar S, Dilworth V, Mick S, Contreras PC, Monahan J, Rao T, Wood PL (1990) Sigma receptors modulate A9 and A10 dopaminergic neurons in the rat brain: functional interaction with NMDA receptors. Brain Res 524: 322-326
11. Monnet FP, DeBonnel G, Junien J-L, De Montigny C (1990) N-Methyl D-aspartate-induced neuronal activation is selectively modulated by σ receptors. Eur J Pharmacol 179:441-445
12. Monnet FP, DeBonnel G, De Montigny C (1992) In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands. J Pharmacol Exp Ther 261: 123-130
13. Patrick SL, Walker JM, Perkel JM, Lockwood M, Patrick RL (1993) Increases in rat striatal extracellular dopamine and vacuous chewing produced by two sigma liagands. Eur J Pharmacol 231: 243-249
14. Paxinos G, Watson C (1986) The rat brain in stereotaxic coodinates. Academic Press, New York
15. Pehck E, Yamamoto B (1994) Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen. J Neurochem 63: 2118-2124
16. 3H]haloperidol binding in guinea pig brain membranes. Proc Natl Acad Sci 81: 5618-5621
17. Weiser SD, Patrick SL, Mascarella S, Downing-Park J, Bai X, Carroll F, Walker JM, Patrick RL (1995) Stimulation of rat striatal tyrosine hydroxylase activity following intranigral administration of a receptor ligands. Eur J Pharmacol 275: 1-7